Publications and reports

Find a list of publications and cancer reports that use data held by the Cancer Institute NSW.

Below is a list of publications that use data held by the Cancer Institute NSW.  

This includes:

  • NSW Cancer Registry
  • NSW Clinical Cancer Registry (2008–2012)
  • BreastScreen NSW
  • NSW Pap Test Register
  • Cancer Institute Tobacco Tracking Survey
Published date 16 May 2016
library_books E-cigarette use by smokers in New South Wales is highest among young people, a new Cancer Institute NSW study shows.
Published date 16 May 2016
library_books There is a substantial lack of well organised processes to ensure that people with suspected lung cancer in rural and remote areas are referred and assessed appropriately. This must change.
Published date 15 May 2016
library_books More than one in three breast cancer deaths in the West Midlands would have been avoided if survival had been the same as in New South Wales.
Published date 15 May 2016
library_books In New South Wales, survival was similar amongst affluent and deprived women, regardless of whether their breast cancer was screen-detected or not. In the West Midlands, there were large and persistent differences in survival between affluent and deprived women.
Published date 10 May 2016
library_books Treatment with statins does not influence cancer incidence or death from non-cardiovascular causes in patients with coronary heart disease.
Published date 01 May 2016
library_books Type 1 diabetes was associated with differences in the risk of several common cancers. The risk declined with increasing diabetes duration.
Published date 01 May 2016
library_books Adults who receive allogeneic haematopoietic stem cell transplants have an increased risk of second cancers and death.
Published date 15 April 2016
library_books Current, but not past, use of menopausal hormone therapy is associated with a substantially increased risk of breast cancer.
Published date 01 April 2016
library_books Compared with non-Aboriginal people, Aboriginal people had a higher risk of cancer death and higher likelihood of more advanced stage across socio-economic disadvantage and remoteness categories.